6.13
+0.46
+(8.11%)
At close: January 10 at 4:00:02 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 2 | 3 |
| Avg. Estimate | -0.88 | -0.82 | -4.07 | -3 |
| Low Estimate | -0.99 | -0.82 | -4.17 | -4.1 |
| High Estimate | -0.76 | -0.82 | -3.96 | -1.78 |
| Year Ago EPS | -3.78 | -1.15 | -6.96 | -4.07 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.03 | -1.09 | -0.96 | -0.73 |
| EPS Actual | -3.78 | -1.15 | -0.64 | -1.39 |
| Difference | -2.75 | -0.06 | 0.32 | -0.66 |
| Surprise % | -266.99% | -5.50% | 33.33% | -90.41% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.88 | -0.82 | -4.07 | -3 |
| 7 Days Ago | -0.81 | -0.73 | -3.31 | -2.57 |
| 30 Days Ago | -0.79 | -0.73 | -3.38 | -3.03 |
| 60 Days Ago | -0.79 | -0.73 | -3.38 | -3.03 |
| 90 Days Ago | -0.8 | 0 | -3.67 | -3.07 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 2 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ELTX | 76.72% | 28.70% | 41.59% | 26.12% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Initiated | Jones Trading: Buy | 10/31/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/1/2024 |
| Reiterates | Oppenheimer: Perform to Perform | 4/1/2024 |
Related Tickers
PHVS Pharvaris N.V.
17.80
-3.99%
CRGX CARGO Therapeutics, Inc.
13.50
-4.93%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.60
-3.55%
ENGN enGene Holdings Inc.
7.61
-6.05%
ENTX Entera Bio Ltd.
2.4500
0.00%
GNFT Genfit S.A.
3.6000
0.00%
IPHA Innate Pharma S.A.
1.7700
-1.67%
ARVN Arvinas, Inc.
18.62
-6.05%
DMAC DiaMedica Therapeutics Inc.
5.27
-3.48%
ACOG Alpha Cognition Inc. Common Stock
6.10
+6.56%